Recent articles indicate that the intrathecal pre-treatment of RvE1 prohibits the induction of nerve injury-induced nociception and increases in Iba-1 (microglial marker) and TNF-α (brain inflammation) in mice spinal cords. The gene discussed is TNF; the disease is brain inflammatory disease.